A systematic review and meta-analysis assessed the efficacy and safety of cetuximab maintenance therapy in metastatic colorectal cancer, pooling data on progression-free survival, overall survival, and adverse effects through March 2026. (Front Pharmacol)
CRC Research Finding
The CRC Digest